Should all breast cancers be diagnosed by needle biopsy?

Lannin, Donald R.; Ponn, Teresa; Andrejeva, Liva; Philpotts, Liane E.

doi:10.1016/j.amjsurg.2006.06.008

Cited by 18 publications

(5 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Although most suspected papillary lesions in this series were excised without PNB, it is widely used for diagnosis [15]. Patient preference has been cited as a common indication for primary open SB breast diagnosis [8], an observation also reported by Lannin [16]. This study clearly indicates that in a center where PNB is routinely used and readily available, with appropriate counseling where required, most patients are very accepting of PNB for diagnosis.…”

Section: Discussionsupporting

confidence: 61%

Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators

2015

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 61%

Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators

2015

View full text Add to dashboard Cite

show abstract

“…For those with cancer, preoperative diagnosis allows better treatment planning and improved patient education regarding the alternative treatment options. [16] In patients with PCa, surgical castration or the use of other methods that lead to a decrease of testicular androgen production and of plasma testosterone levels usually results in a favorable response. [17] This form of therapy is commonly applied to either locally advanced or metastatic PCa.…”

Section: Discussionmentioning

confidence: 99%

Diagnosis of prostate cancer with needle biopsy: Should all cases be biopsied before treatment?

2012

View full text Add to dashboard Cite

Needle biopsy of the prostate is the preferred method for the diagnosis of PCa in most cases before treatment is undertaken. There are valid reasons why all PCas will not be diagnosed in this fashion. Elevated PSA when combined with an abnormal DRE finding increases the predictive value for cancer. In areas where pathologists are lacking, abnormal DRE and elevated PSA results can be a guide to proceed to treatment especially, where there is severe compromise of patients' quality of life due to symptoms of advanced PCa while awaiting confirmation.

show abstract

“…Similarly, US-guided core needle biopsy of lesions in augmented breasts can theoretically be performed safely and accurately because of its use of real-time US to visualize both the lesion and the implant during biopsy. Percutaneous imaging-guided core needle biopsy in breasts with implants may be safe and accurate [24,[33][34][35], but the rate of implant rupture during percutaneous imaging-guided core needle biopsy is not well known. Although an excisional biopsy is believed to be safer to avoid damage to the implant when lesions are adjacent to an implant [35], to my knowledge, there are no reports about implant rupture during percutaneous imaging-guided core needle biopsy.…”

Section: Core Needle Biopsy For Augmented Breastsmentioning

confidence: 98%

Screening and diagnosis of breast cancer in augmented women

Uematsu

2008

Breast Cancer

View full text Add to dashboard Cite

Cosmetic breast enlargement surgery has become common in Japan. There are some reports suggesting that implants can interfere with mammography (MMG) and may lead to delayed breast cancer diagnosis, even when implant-displaced MMG (Eklund technique) is performed. Screening MMG was recommended in a notification issued by the Japanese Ministry of Health, Labor and Welfare in 1999, and MMG is just coming into widespread use in Japanese breast cancer screening. Recent reports suggest that screening MMG may not be appropriate in augmented women, but breast self-examination may be effective in these women. Ultrasonography (US) may be useful in screening augmented women without risk of rupturing the implant. In appropriate cases, magnetic resonance imaging should be considered as an adjunct to MMG and US. The question of whether augmented women should not undergo core needle biopsy because of the possibility of damage to the implant should be considered. This review discusses diagnostic methods for augmented women and suggests the optimal screening method for augmented women. The challenge of the screening and diagnosis of breast cancer in augmented women is important in order to detect more of their cancer at a preclinical stage, because we can expect to see breast cancer in augmented women with increasing frequency over the next decade.

show abstract

Should all breast cancers be diagnosed by needle biopsy?

Cited by 18 publications

References 20 publications

Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators

Utilization of Percutaneous Needle Biopsy for Breast Diagnosis in a Comprehensive Breast Center: Implications for Development of Quality Indicators

Diagnosis of prostate cancer with needle biopsy: Should all cases be biopsied before treatment?

Screening and diagnosis of breast cancer in augmented women

Contact Info

Product

Resources

About